Search

Your search keyword '"Sy, O"' showing total 217 results

Search Constraints

Start Over You searched for: Author "Sy, O" Remove constraint Author: "Sy, O"
217 results on '"Sy, O"'

Search Results

11. ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016

13. Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase-2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts

14. P700: TREATMENT-FREE REMISSION (TFR) AFTER DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND DEEP MOLECULAR RESPONSE (DMR): FINAL 5-YEAR RESULTS OF DASFREE

15. P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS

16. Evolution of the Ace-1 and Gste2 mutations and their potential impact on the use of carbamate and organophosphates in IRS for controlling Anopheles gambiae s.l., the major malaria mosquito in Senegal

18. RainCube and MASC in PECAN

24. IMPACTS OF NATURAL AND ANTHROPOGENIC FACTORS ON THE WOODY FLORA OF HAUTE-CASAMANCE (SOUTH SENEGAL): FROM PERCEPTION TO REALITY

32. Analyse comparée de collectivités locales dans le système dendroénergétique de la ville de Bakel (Sénégal)

33. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4-year follow-up and analysis of relative progression-free survival from the randomized ELOQUENT-2 trial

35. PF408 DASFREE 2-YEAR UPDATE: DASATINIB DISCONTINUATION IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND DEEP MOLECULAR RESPONSE (DMR)

36. PF405 DASCERN 2-YEAR EXTENDED FOLLOW-UP OF DASATINIB EFFICACY AND SAFETY IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WHO HAVE SUBOPTIMAL RESPONSES TO 3 MONTHS OF IMATINIB

38. Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma From the Phase 2 CheckMate 205 Study

40. Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth

41. IMPLICATIONS OF FARMER PERCEIVED PRODUCTION CONSTRAINTS AND VARIETAL PREFERENCES TO PEARL MILLET BREEDING IN SENEGAL.

49. Efficacité de trois larvicides d’origine biologique et d’un régulateur de croissance contre Anopheles arabiensis au Sénégal

Catalog

Books, media, physical & digital resources